Advertisement
Screener

ACADIA PHARMACEUTICALS INC. (ACAD) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ACADIA PHARMACEUTICALS INC. Cash Flow Breakdown

Cash flow breakdown shows where ACADIA PHARMACEUTICALS INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $109.84M came in.
  • Fiscal year ended 2025-12-31: from investing, $302.56M went out.
  • Fiscal year ended 2025-12-31: from financing, $49.88M came in.
  • Fiscal year ended 2025-12-31: change in cash, $142.82M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew shares soldOtherNot split outChange in cash
2025-12-31$109.84M-$302.56M$49.88M-$142.82M
2024-12-31$157.72M-$30.54M$6.84M$133.93M
2023-12-31$16.70M$32.00M$25.13M$73.81M
2022-12-31-$114.03M$73.24M$8.20M-$32.59M
2021-12-31-$125.66M-$71.10M$18.16M-$178.59M
2020-12-31-$136.17M$192.51M$81.00M$137.33M
2019-12-31-$151.13M-$165.84M$371.85M$54.88M
2018-12-31-$167.47M-$71.49M$306.65M$67.69M
2017-12-31-$217.76M$92.47M$31.19M-$94.10M
2016-12-31-$208.41M-$261.92M$518.90M$596.00K$14.32M*$63.48M
2015-12-31-$121.80M$147.57M$14.55M$247.00K$40.28M
2014-12-31-$66.43M-$87.27M$203.85M$50.15M
2013-12-31-$31.77M-$126.10M$111.68M-$46.19M
2012-12-31-$21.63M-$25.53M$98.20M$51.01M
2011-12-31-$19.90M$5.98M-$78.00K$14.02M$40.00K
2010-12-31-$10.70M-$1.06M-$353.00K$823.00K-$11.27M
2009-12-31-$13.73M$9.44M-$762.00K$1.92M-$3.05M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2026-06-30$100.78M*-$8.53M*$10.49M*
2026-03-31$33.98M$66.28M$4.23M$104.52M
2025-12-31-$48.73M*-$55.87M*$22.67M*
2025-09-30$74.29M*-$79.35M*$9.42M*
2025-06-30$63.96M*-$43.29M*$15.96M*
2025-03-31$20.32M-$124.05M$1.84M-$101.89M
2024-12-31$40.38M*$122.15M*$1.97M*
2024-09-30$63.25M*-$82.46M*$268.00K*
2024-06-30$25.01M*-$56.19M*$3.56M*
2024-03-31$29.08M-$14.04M$1.04M$16.09M
2023-12-31$85.39M*-$347.00K*$5.43M*
2023-09-30-$58.95M*$34.11M*$12.75M*
2023-06-30$8.20M*-$194.28M*$5.48M*
2023-03-31-$17.93M$192.52M$1.47M$176.05M
2022-12-31-$23.85M*-$17.75M*$1.61M*
2022-09-30-$727.00K*$15.44M*$287.00K*
2022-06-30-$13.13M*-$55.80M*$3.83M*
2022-03-31-$76.33M$131.34M$2.47M$57.48M
2021-12-31-$23.12M*$71.55M*$4.37M*
2021-09-30-$17.06M*-$156.32M*$1.07M*
2021-06-30-$25.33M*-$17.21M*$5.00M*
2021-03-31-$60.15M$30.88M$7.73M-$21.54M
2020-12-31-$27.49M*-$116.96M*$18.13M*
2020-09-30-$22.79M*$152.99M*$11.71M*
2020-06-30-$36.88M*$126.86M*$47.40M*
2020-03-31-$49.00M$29.61M$3.75M-$15.64M
2019-12-31-$29.71M*-$209.14M*$43.06M*
2019-09-30-$18.85M*$9.92M*$319.97M*
2019-06-30-$38.40M*$10.63M*$4.65M*
2019-03-31-$64.17M$22.76M$4.18M-$37.24M
2018-12-31-$39.08M*-$188.95M*$300.60M*
2018-09-30-$42.28M*$31.78M*$211.00K*
2018-06-30-$40.88M*-$3.94M*$2.95M*
2018-03-31-$45.24M$89.62M$2.88M$47.26M
2017-12-31-$29.89M*-$18.09M*$4.79M*-$43.20M*
2017-09-30-$58.40M*$19.33M*$7.90M*-$31.17M*
2017-06-30-$59.00M*$38.30M*$7.01M*-$13.59M*
2017-03-31-$70.56M$52.94M$11.49M-$6.14M
2016-12-31-$63.19M*$69.14M*$3.39M*$596.00K*$9.94M*
2016-09-30-$49.26M*-$154.91M*$226.08M*$21.91M*
2016-06-30-$56.74M*-$7.46M*$6.44M*$14.32M*-$43.45M*
2016-03-31-$41.21M-$168.70M$282.99M$73.08M
2015-12-31-$34.72M*$56.73M*$9.38M*$31.34M*
2015-09-30-$31.85M*$8.31M*$1.13M*-$22.41M*
2015-06-30-$29.87M*$44.06M*$2.60M*$16.79M*
2015-03-31-$25.35M$38.47M$1.44M$14.57M
2014-12-31-$17.80M*$40.48M*$2.81M*$25.48M*
2014-09-30-$17.48M*$38.87M*$1.28M*$22.67M*
2014-06-30-$16.97M*-$67.51M*$1.72M*-$82.76M*
2014-03-31-$14.18M-$99.11M$198.04M$84.75M
2013-12-31-$10.27M*$9.54M*$629.00K*-$96.00K*
2013-09-30-$9.47M*-$3.94M*$974.00K*-$12.44M*
2013-06-30-$5.44M*-$98.62M*$109.87M*$5.81M*
2013-03-31-$6.58M-$33.09M$208.00K-$39.46M
2012-12-31-$6.30M*-$35.05M*$91.24M*$49.88M*
2012-09-30-$5.31M*-$2.74M*$6.80M-$1.19M*
2012-06-30-$4.80M*$8.39M*$67.00K*$3.65M*
2012-03-31-$5.23M$3.88M-$9.00K$31.00K-$1.33M
2011-12-31-$5.34M*$3.81M*-$9.00K*$106.00K*-$1.43M*
2011-09-30-$4.17M*$4.48M*-$12.00K*$2.00K*$297.00K*
2011-06-30-$5.28M*$6.42M*-$14.00K*$61.00K*$1.19M*
2011-03-31-$5.11M-$8.73M-$43.00K$13.85M-$20.00K
2010-12-31$4.60M*-$7.76M*-$42.00K*$401.00K*-$2.81M*
2010-09-30-$2.52M*$2.94M*-$60.00K*$378.00K*$845.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47